Matches in SemOpenAlex for { <https://semopenalex.org/work/W2135175231> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2135175231 endingPage "509" @default.
- W2135175231 startingPage "504" @default.
- W2135175231 abstract "OBJECTIVE—To describe secondary failure of initial metformin therapy in patients who achieved initial HbA1c (A1C) <8% and to identify predictors of failure. RESEARCH DESIGN AND METHODS—We identified 1,288 patients who achieved A1C <8% within 1 year of initiating metformin as their first-ever antihyperglycemic drug. Subjects were followed until they added/switched antihyperglycemics, they terminated health plan membership, or 31 December 2004. We defined secondary failure using two separate but overlapping approaches: 1) addition/switch to another antihyperglycemic drug or 2) first A1C measurement >8.0% after at least 6 months on metformin. RESULTS—The best A1C achieved within 1 year of metformin initiation was the most powerful predictor of avoiding secondary failure. Approximately 50% of subjects whose best A1C was 7–7.9% added/switched antihyperglycemic drugs within 36 months, whereas it took >60 months for those in the 6–6.9% A1C category to reach a 50% failure rate. Those who achieved an A1C <6% did not reach a 50% rate of adding/switching drugs until 84 months. For the alternative secondary failure outcome, about half of those whose best A1C was 7.0–7.9% reached an A1C >8% within 24 months. Only ∼25% of subjects in the 6–6.9% category failed by 48 months, and >80% of subjects in the <6% category remained below 8% through 60 months. CONCLUSIONS—Whether defined by adding/switching to another drug or by reaching an A1C of 8%, secondary failure is inversely associated with the reduction of A1C achieved within the 1st year of metformin monotherapy." @default.
- W2135175231 created "2016-06-24" @default.
- W2135175231 creator A5027170050 @default.
- W2135175231 creator A5042740100 @default.
- W2135175231 creator A5079115002 @default.
- W2135175231 creator A5082531351 @default.
- W2135175231 creator A5085651267 @default.
- W2135175231 date "2006-03-01" @default.
- W2135175231 modified "2023-09-23" @default.
- W2135175231 title "Treatment Escalation and Rise in HbA1c Following Successful Initial Metformin Therapy" @default.
- W2135175231 cites W1975588287 @default.
- W2135175231 cites W1976567448 @default.
- W2135175231 cites W1982646036 @default.
- W2135175231 cites W1986302821 @default.
- W2135175231 cites W2006030514 @default.
- W2135175231 cites W2009804272 @default.
- W2135175231 cites W2057112394 @default.
- W2135175231 cites W2063392732 @default.
- W2135175231 cites W2069150029 @default.
- W2135175231 cites W2097112828 @default.
- W2135175231 cites W2113322194 @default.
- W2135175231 cites W2169735327 @default.
- W2135175231 cites W2188846692 @default.
- W2135175231 cites W2337454357 @default.
- W2135175231 cites W4238183455 @default.
- W2135175231 cites W4255078542 @default.
- W2135175231 cites W52391068 @default.
- W2135175231 doi "https://doi.org/10.2337/diacare.29.03.06.dc05-1937" @default.
- W2135175231 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16505496" @default.
- W2135175231 hasPublicationYear "2006" @default.
- W2135175231 type Work @default.
- W2135175231 sameAs 2135175231 @default.
- W2135175231 citedByCount "71" @default.
- W2135175231 countsByYear W21351752312012 @default.
- W2135175231 countsByYear W21351752312013 @default.
- W2135175231 countsByYear W21351752312014 @default.
- W2135175231 countsByYear W21351752312015 @default.
- W2135175231 countsByYear W21351752312016 @default.
- W2135175231 countsByYear W21351752312017 @default.
- W2135175231 countsByYear W21351752312019 @default.
- W2135175231 countsByYear W21351752312021 @default.
- W2135175231 countsByYear W21351752312022 @default.
- W2135175231 crossrefType "journal-article" @default.
- W2135175231 hasAuthorship W2135175231A5027170050 @default.
- W2135175231 hasAuthorship W2135175231A5042740100 @default.
- W2135175231 hasAuthorship W2135175231A5079115002 @default.
- W2135175231 hasAuthorship W2135175231A5082531351 @default.
- W2135175231 hasAuthorship W2135175231A5085651267 @default.
- W2135175231 hasBestOaLocation W21351752311 @default.
- W2135175231 hasConcept C126322002 @default.
- W2135175231 hasConcept C134018914 @default.
- W2135175231 hasConcept C2780035454 @default.
- W2135175231 hasConcept C2780323712 @default.
- W2135175231 hasConcept C555293320 @default.
- W2135175231 hasConcept C71924100 @default.
- W2135175231 hasConcept C98274493 @default.
- W2135175231 hasConceptScore W2135175231C126322002 @default.
- W2135175231 hasConceptScore W2135175231C134018914 @default.
- W2135175231 hasConceptScore W2135175231C2780035454 @default.
- W2135175231 hasConceptScore W2135175231C2780323712 @default.
- W2135175231 hasConceptScore W2135175231C555293320 @default.
- W2135175231 hasConceptScore W2135175231C71924100 @default.
- W2135175231 hasConceptScore W2135175231C98274493 @default.
- W2135175231 hasIssue "3" @default.
- W2135175231 hasLocation W21351752311 @default.
- W2135175231 hasLocation W21351752312 @default.
- W2135175231 hasOpenAccess W2135175231 @default.
- W2135175231 hasPrimaryLocation W21351752311 @default.
- W2135175231 hasRelatedWork W1966504330 @default.
- W2135175231 hasRelatedWork W1979139803 @default.
- W2135175231 hasRelatedWork W2005084305 @default.
- W2135175231 hasRelatedWork W2016264464 @default.
- W2135175231 hasRelatedWork W2033313326 @default.
- W2135175231 hasRelatedWork W2037631372 @default.
- W2135175231 hasRelatedWork W2040058909 @default.
- W2135175231 hasRelatedWork W2132898409 @default.
- W2135175231 hasRelatedWork W2744240433 @default.
- W2135175231 hasRelatedWork W2748952813 @default.
- W2135175231 hasVolume "29" @default.
- W2135175231 isParatext "false" @default.
- W2135175231 isRetracted "false" @default.
- W2135175231 magId "2135175231" @default.
- W2135175231 workType "article" @default.